Rendering of Lilly's new Indiana site at the LEAP Research and Innovation District (Credit: Eli Lilly)
May 24, 2024 11:48 AM EDT
Manufacturing

Lil­ly bud­gets ad­di­tion­al $5.3B for tirzepatide API fac­to­ry in In­di­ana

Anna Brown

News Reporter

Eli Lil­ly is fur­ther boost­ing man­u­fac­tur­ing in its home state of In­di­ana.

The com­pa­ny said it is al­lo­cat­ing an ad­di­tion­al $5.3 bil­lion in­to its bud­get …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Au­toim­mune CAR-T da­ta dump: Kyver­na, Ca­balet­ta shares fall af­ter un­veil­ing ear­ly-stage re­sults

Gilead can­cer drug ma­grolimab showed wor­ry­ing trends around death

Stephen Squin­to talks writ­ing checks and next-gen obe­si­ty drugs as JP Mor­gan clos­es first $500M+ biotech fund

Up­dat­ed: Telix Phar­ma­ceu­ti­cals pulls Nas­daq list­ing plans just be­fore trad­ing was to start

Rare pe­di­atric dis­ease vouch­ers face un­cer­tain fu­ture af­ter Sep­tem­ber

sponsored

De-risk­ing the pa­tient jour­ney in cell ther­a­pies: Six key con­sid­er­a­tions

A service from the Financial Times